Single-cell RNA sequencing reveals the pro-inflammatory roles of liver-resident Th1-like cells in primary biliary cholangitis
Author:
Funder
National Natural Science Foundation of China
Natural Science Foundation of Zhejiang Province
Publisher
Springer Science and Business Media LLC
Link
https://www.nature.com/articles/s41467-024-53104-9.pdf
Reference63 articles.
1. Gulamhusein, A. F. & Hirschfield, G. M. Primary biliary cholangitis: pathogenesis and therapeutic opportunities. Nat. Rev. Gastroenterol. Hepatol. 17, 93–110 (2020).
2. Boonstra, K., Beuers, U. & Ponsioen, C. Y. Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review. J. Hepatol. 56, 1181–1188 (2012).
3. Shah, R. A. & Kowdley, K. V. Current and potential treatments for primary biliary cholangitis. Lancet Gastroenterol. Hepatol. 5, 306–315 (2020).
4. Combes, B. et al. Methotrexate (MTX) plus ursodeoxycholic acid (UDCA) in the treatment of primary biliary cirrhosis. Hepatology 42, 1184–1193 (2005).
5. Gonzalez-Koch, A., Brahm, J., Antezana, C., Smok, G. & Cumsille, M. A. The combination of ursodeoxycholic acid and methotrexate for primary biliary cirrhosis is not better than ursodeoxycholic acid alone. J. Hepatol. 27, 143–149 (1997).
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Macrophage heterogeneity in autoimmune diseases;Cellular Immunology;2025-08
2. Single-cell transcriptomic atlas reveals the underlying mechanism of indole-3-acetic acid in protecting against acute cholestatic liver injury;Phytomedicine;2025-08
3. New insights into the pharmacological mechanisms of Jinqi Jiangtang Tablets in the treatment of type 2 diabetes mellitus: A multi-omics approach combined with experimental validation;Journal of Ethnopharmacology;2025-06
4. Reviewing the function of macrophages in liver disease;Expert Review of Gastroenterology & Hepatology;2025-05-21
5. Immunology of Autoimmune Liver Diseases;Reference Module in Life Sciences;2025
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.7亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2025 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3